BACKGROUND: Distinct CD8+ T-cell subsets such as interleukin-17-expressing Tc17 and Foxp3-expressing Tcreg are functionally similar to CD4+ T cells. Though CD4+ T cells are dysregulated in patients with inflammatory bowel disease (IBD), CD8+ T cells are not well investigated. Vitamin D is an environmental factor which influences T-cell subsets. We assessed the prevalence of CD8+ T-cell subsets among peripheral blood mononuclear cells (PBMC) and lamina propria mononuclear cells (LPMC) of patients with Crohn's disease, patients with ulcerative colitis, and healthy controls. We then tested the effect of 1α,25-dihydroxyvitamin D3 on CD8+ T-cell subsets. METHODS: A total of 73 patients with Crohn's disease, 49 patients with ulcerative colitis, and 47 healthy controls were studied. LPMC or PBMC were isolated and flow cytometry was performed. CD3+ T cells, isolated from PBMC, were cultured with or without 1α,25-dihydroxyvitamin D3, before flow cytometry. RESULTS: In LPMC, the prevalence of Tcreg was higher in patients with IBD (P < 0.05), whereas Tc17 were higher in patients with ulcerative colitis compared with patients with Crohn's disease and healthy controls (P < 0.05). In PBMC, both Tcreg and Tc17 were higher in patients with IBD (P < 0.01). Double-expressing interferon-γ+ interleukin-17+ and Foxp3+ interleukin-17+ CD8+ T cells were also identified indicating possible CD8+ plasticity. 1α,25-dihydroxyvitamin D3 decreased interferon-γ-expressing Tc1 (P < 0.05), but had no effect on Tc17 or Tcreg. CONCLUSIONS: The prevalence of novel CD8+ T-cell subsets is altered in patients with IBD. Double-expressing cells indicate plasticity and were identified in patients with IBD. Vitamin D may have a limited effect on CD8+ T cells by decreasing interferon-γ expression.
BACKGROUND: Distinct CD8+ T-cell subsets such as interleukin-17-expressing Tc17 and Foxp3-expressing Tcreg are functionally similar to CD4+ T cells. Though CD4+ T cells are dysregulated in patients with inflammatory bowel disease (IBD), CD8+ T cells are not well investigated. Vitamin D is an environmental factor which influences T-cell subsets. We assessed the prevalence of CD8+ T-cell subsets among peripheral blood mononuclear cells (PBMC) and lamina propria mononuclear cells (LPMC) of patients with Crohn's disease, patients with ulcerative colitis, and healthy controls. We then tested the effect of 1α,25-dihydroxyvitamin D3 on CD8+ T-cell subsets. METHODS: A total of 73 patients with Crohn's disease, 49 patients with ulcerative colitis, and 47 healthy controls were studied. LPMC or PBMC were isolated and flow cytometry was performed. CD3+ T cells, isolated from PBMC, were cultured with or without 1α,25-dihydroxyvitamin D3, before flow cytometry. RESULTS: In LPMC, the prevalence of Tcreg was higher in patients with IBD (P < 0.05), whereas Tc17 were higher in patients with ulcerative colitis compared with patients with Crohn's disease and healthy controls (P < 0.05). In PBMC, both Tcreg and Tc17 were higher in patients with IBD (P < 0.01). Double-expressing interferon-γ+ interleukin-17+ and Foxp3+ interleukin-17+ CD8+ T cells were also identified indicating possible CD8+ plasticity. 1α,25-dihydroxyvitamin D3 decreased interferon-γ-expressing Tc1 (P < 0.05), but had no effect on Tc17 or Tcreg. CONCLUSIONS: The prevalence of novel CD8+ T-cell subsets is altered in patients with IBD. Double-expressing cells indicate plasticity and were identified in patients with IBD. Vitamin D may have a limited effect on CD8+ T cells by decreasing interferon-γ expression.
Authors: Christopher S Smillie; Moshe Biton; Jose Ordovas-Montanes; Keri M Sullivan; Grace Burgin; Daniel B Graham; Rebecca H Herbst; Noga Rogel; Michal Slyper; Julia Waldman; Malika Sud; Elizabeth Andrews; Gabriella Velonias; Adam L Haber; Karthik Jagadeesh; Sanja Vickovic; Junmei Yao; Christine Stevens; Danielle Dionne; Lan T Nguyen; Alexandra-Chloé Villani; Matan Hofree; Elizabeth A Creasey; Hailiang Huang; Orit Rozenblatt-Rosen; John J Garber; Hamed Khalili; A Nicole Desch; Mark J Daly; Ashwin N Ananthakrishnan; Alex K Shalek; Ramnik J Xavier; Aviv Regev Journal: Cell Date: 2019-07-25 Impact factor: 41.582
Authors: A-M Globig; A V Hipp; P Otto-Mora; M Heeg; L S Mayer; S Ehl; H Schwacha; M Bewtra; V Tomov; R Thimme; P Hasselblatt; B Bengsch Journal: Nat Commun Date: 2022-06-27 Impact factor: 17.694
Authors: Alexandra Schnell; Linglin Huang; Meromit Singer; Anvita Singaraju; Rocky M Barilla; Brianna M L Regan; Alina Bollhagen; Pratiksha I Thakore; Danielle Dionne; Toni M Delorey; Mathias Pawlak; Gerd Meyer Zu Horste; Orit Rozenblatt-Rosen; Rafael A Irizarry; Aviv Regev; Vijay K Kuchroo Journal: Cell Date: 2021-12-06 Impact factor: 41.582
Authors: Luciano G Morosi; Anabela M Cutine; Alejandro J Cagnoni; Montana N Manselle-Cocco; Diego O Croci; Joaquín P Merlo; Rosa M Morales; María May; Juan M Pérez-Sáez; María R Girotti; Santiago P Méndez-Huergo; Betiana Pucci; Aníbal H Gil; Sergio P Huernos; Guillermo H Docena; Alicia M Sambuelli; Marta A Toscano; Gabriel A Rabinovich; Karina V Mariño Journal: Sci Adv Date: 2021-06-18 Impact factor: 14.136
Authors: Kathryn J A Steel; Ushani Srenathan; Michael Ridley; Lucy E Durham; Shih-Ying Wu; Sarah E Ryan; Catherine D Hughes; Estee Chan; Bruce W Kirkham; Leonie S Taams Journal: Arthritis Rheumatol Date: 2020-02-04 Impact factor: 10.995
Authors: Marco Gasparetto; Felicity Payne; Komal Nayak; Judith Kraiczy; Claire Glemas; Yosef Philip-McKenzie; Alexander Ross; Rachel D Edgar; Daniel R Zerbino; Camilla Salvestrini; Franco Torrente; Nicholas T Ventham; Rahul Kalla; Jack Satsangi; Peter Sarkies; Robert Heuschkel; Matthias Zilbauer Journal: Gastroenterology Date: 2020-08-16 Impact factor: 22.682